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Binding of nuclcotides, a tctrapolyphosphate. and NAD’ to purified toxin A of Clnstridirarl dlficile was dctcrmincd by monitoring changes in 
intrinsic fluorescence following excitation at 280 nm. and recording emissions at 340 nm. Binding was specific for concentrations over the range 
5 lo 100 FM for ATP, GTP. and their respective nonahydrolysable analogues AMP-PNP and Cipp(NH)p. tctrapolyphosphatc nd NAD’. 
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1. INTRODUCTION 2.2. Fluorescertce d/Q-Jerence specmorr OJ roxitr A 
Fluorescence was dctcrmined with a Pcrkin-Elmer LS-5 Lumi- 
nescencc Spcctromcter containing a thermostatically controlled cu- 
vctte holder. The excitation and emission slits were xt a~ 20 nm and 
IO nm respectively. The fiuorescencc difference spectrum of a solution 
of toxin A in 20 mM Tris versus toxin A-free buflier was performed 
bctwccn 290 and 380 nm following excitation of the samplesat 280 nm. 
The emission spectrum of 10 ,uM free tryptophan (Sigma) was also 
pcrl’ormccl at the same wavelengths. 
Closrridiunz d@?cile is a well established cause of 
pseudomembranous colitis and also accounts for a sig- 
nificant proportion of cases of antibiotic-associated 
diarrhoea [I ,2]. Of the known and putative virulence 
factors described [3] the most important in terms of 
contributing to the features of the disease are the two 
major toxins, designated A and B, and in particular 
toxin A [4,5]. Our understanding of the structure and 
functions of these two toxins is limited, particularly of 
any structure-function relationships [6]. It has been 
demonstrated that toxin B has a polyphosphate binding 
site and will specifically bind ATP [?I. Whether or not 
toxin A also has this function is unknown. We therefore 
undertook a study to determine this and to examine the 
possibility of an NAD’ binding site based on the 
method of monitoring protein conformational changes 
by following changes in intrinsic tryptophan fluores- 
cence. 
2. MATERIALS AND METHODS 
2. I. Preparation oJ’ toxirt A 
Toxin A was prepared in pure form from C. rliJ/?cilr VP1 10463 as 
described in detail previously [S]. Briefly, the procedure consisted of 
passing crude culture filtrate through a bovine thyroglobulin atIinity 
column ud 4°C (which retains toxin A) and thermal elution at 37°C. 
This product is further purified by two sequential anion-exchange 
chromatographic sl ps (Q Sepharose FF and Mono Q) by fast protein 
liquid chromatography (Pharmacia). The purified toxin A preparation 
was dialyscd at 4°C overnight against 20 mM Tris-buffer at pi-i 7.5, 
and kept stored at 4°C. 
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Titration of the intrinsic Ruorescenceoftoxin A with ATP and GTP 
(sodium salts, Sigma), their respective non-hydrolysable analogucs 
AMP-PNP. and Gpp(NH)p (lithium salts, Boehringer Mannheim). 
tctrapolyphosphatc (h xnammonium salt, Sigma), and@icotinamidc 
adcninc dinuclcotide (NAD’, Bochringcr Mannheim), were pcr- 
formed by adding 5-25 ~1 increments of I mM substrate in 20 mM 
Tris. pH 7.5, to a I ml solution of approximately 100 p@rnl of toxin 
A in the same buffer. The samples were carefully stirred after each 
addition, ensuring that light was always excluded from the system. 
Titrations were performed at 30°C Thedeclinc in protein fluorescence 
following excitnlion at 280 nm was measured at 340 nm emission. In 
order to correct for inner filter effects, asolution of tryptophan, of the 
sume initial fluorcscencc as the protein solution, was similarly titrated 
with all substrates and corrections made according to the method of 
Honorc Hnd Pcdcrsen 191. Measurements were corrected for dilution. 
2,4. Uittditrg 01 toxia A to ATP-agarosc 
Toxin A (0.2 ml of a 100 j@ml solution) was applied to a column 
of ATP-agarosc (1 cm x 0.5 cm, Sigma) containing 7 ymol ATP, the 
column left for 2 h at room tcmperdture. then washed with 20 mM 
Tris, pH 7.4. The amount of toxin A bound to the column was deter- 
mined by estimating the amount of toxin A that clutcd. The expcri- 
mcnt was conducted 3times and the triplicate mean record&d. 
2.5. Protein estinratiott 
Protein concentrations were detcrmincd by the method of Lowry ct 
al. [IO]. 
3. REWLTS AND DISC’uSSION 
Fluorescence spectroscopy has previously been used 
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to study toxin-liyand interactions and to provide an 
indirect method for determining fractional saturation. 
For example the binding of NAD’ to diphtheria toxin 
fragment A [ 111, Psrudoontottas cwrrgittosa exotoxin A 
[ 121 and pertussis toxin [13], and the interaction of Schi- 
,-osacclzarontycc pombe mitochondical F,-ATPase with 
phosphate and nucleotide [14], have been investigated 
by monitoring the quenching of the proteins’ intrinsic 
fluorescence. 
The emission spectrum from toxin A following excita- 
tion at 280 nm gave 2 peaks, one at 300 nm and the 
other at 340 nm, the latter corresponding to tryptophan 
fluorescence, confirmed by the emission spectrum of 
free tryptophan. Titrations of the intrinsic fluorescence 
of toxin A with nucleotides, NAD’ and the tetrapoly- 
phosphate were thus performed at 280 nm excitation, 
340 nm emission, and an assumption that the reduced 
fluorescence can be correlated with fractional satura- 
tion was made on the observed saturation at higher 
concentrations (ca. 100,~M) of each ligand (Figs. la-t). 
It can be seen from Figs. 2a-f that the binding of nu- 
cleotides, the tetrapolyphosphate and NAD’ is specific 
and of high affinity, and further that binding is greater 
for the tetrapolyphosphate han the nucleotides and 
that binding of the adenosine was greater than for the 
guanosine nucleotides. Of interest in this respect is the 
observation of Florin and Thelestam [7] that adcnosine 
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Fig. 1. Fluorcsccnce titration oT toxin A with (a) ATP. (b) GTP. (c) 
AMP-PNP, (d) Gpp(NH)p. Cc) tetrapolyphosphalc. and (17 NAD’. 
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Fig. 2. Double reciprocal plbl of % change in fluorescence against 
concentration of(n) ATP, (b) GTP, (c) AMP-PNP, Id) Gpp(NH)p, (c) 
tcwapolyphosphatc, (f’) NAD’. Kd values arc calculated from the inter- 
section on the X-axis. 
triphosphates were better able than other nucleotides to 
delay the cytopathogenic effects induced by C. ~+$3cile 
toxin I3 in MRC-5 cells and that a tetrapolyphosphate 
was better than the nucleotides. They also showed, as 
judged by a decrease in cytotoxicity of eluted material, 
that about 20% of a preparation of toxin B was retained 
on an ATP-agarose column [7]. We show here that a 
proportion of toxin A is also retained on an ATP- 
agarose column, but in this case the proportion 
retained, 35 1- G%, is greater than that reported for toxin 
B. It has been shown that toxin A binds to agarose [I 51, 
however others have been unable to confirm this [i6]. 
So, although it is possible that toxin A bound to the 
agarose, it is more likely that retention on the column 
was due to interaction of toxin A with ATP. 
It is difficult to determine the significance of the abil- 
ity of toxin A to bind physiological levels of nucleotides. 
However, that this ability is shared with toxin B is of 
little surprise due to the high degree of similarity 
(63.7%) at the molecular level (Seddon, unpublished) 
based on published seqacnccs fl?,lS], cor;firmed by N- 
terminal analysis of 203 amino acids showing 64% 
homology [193. A number of the other bacterial protein 
toxins have a phosphate binding site [20-231, In some 
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cases these represent well-characterised calmodulin-de- 
pendent adenylate cyclases, e.g. the edema factor of 
Bacilltrs ardmcis and the adenylate cyclase of 
Borcieteila prrtussis [20] which share a conserved 
domain related to the consensus amino acid sequence 
(Gly-X-X-X-X-Gly-Lys-Ser, X = any amino acid) pres- 
ent in many eukaryotic and prokaryotic ATP and GTP 
binding proteins [24]. We were unable to find this con- 
sensus amino acid sequence in toxin A or in the 
published sequence for diphtheria toxin [25,26], which 
has a polyphosphate binding site [22] and shares with 
toxin A some characteristics related to its cytotoxicity 
[27]. In these two respects is of note the above-men- 
tioned relatively high degree of homology between the 
gene sequences for these two toxins. Interestingly, the 
reverse form of the consensus amino acid sequence Gly- 
X-X-X-X-Gly-Lys-Ser is present in toxin B localised at 
amino acid position 359-366 (Seddon and BorrieKo, 
unpublished), though neither toxins A or B have aden- 
ylate cyclase activity [28]. 
The binding of polyphosphorylated compounds by 
toxin A was not restricted to nucleoside phosphates as 
the inorganic tetrapolyphosphate was also bound, the 
binding being greater than for any of the nucleotidcs. 
This is in keeping with the findings for diphtheria toxin 
[22] and the indirect evidence for toxin B [7]. It would 
appear that toxin A has a phosphate binding site 
analogous to the ‘P’ site on fragment B of diphtheria 
toxin [21,22] or the polyanion binding site postulated 
for toxin I3 [7]. Of further interest is the demonstration 
that toxin A binds the nucleoside NAD’, a further fea- 
ture in keeping with other bacterial toxins. In diphtheria 
toxin, the phosphate and nucleoside binding sites are 
distinct but appear to be close to each other in the 
tertiary configuration, contributing to the nucleotide 
binding site [21]. It is unknown if this is also the case for 
toxin A or whether nucleoside binding is a feature of 
toxin B. 
The functions of a phosphate binding site and, for 
toxin A a nucleoside binding site, are unknown for ei- 
ther toxin A or 6. However our demonstration of a 
phosphate binding site in toxin A further confirms the 
similarities between the two toxins, and with a nu- 
cleoside binding site, is in keeping with the presence of 
such sites in other bacterial protein cytotoxins. 
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